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Abstract
Intake of a high-fat meal induces a systemic inflammatory response in the
postprandial which is augmented in obese subjects. However, the underlying
mechanisms of this response have not been fully elucidated. We aimed to
assess the effect of gut microbiota modulation on postprandial inflammatory
response in lean and obese subjects. Ten lean and ten obese subjects with
metabolic syndrome received oral vancomycin 500 mg four times per day for
7 days. Oral high-fat meal tests (50 g fat/m2 body surface area) were per-
formed before and after vancomycin intervention. Gut microbiota composi-
tion, leukocyte counts, plasma lipopolysaccharides (LPS), LPS-binding protein
(LBP), IL-6 and MCP-1 concentrations and monocyte CCR2 and cytokine
expression were determined before and after the high-fat meal. Oral van-
comycin treatment resulted in profound changes in gut microbiota composi-
tion and significantly decreased bacterial diversity in both groups
(phylogenetic diversity pre- versus post-intervention: lean, 56.9  7.8 vs.
21.4  6.6, P < 0.001; obese, 53.9  7.8 vs. 21.0  5.9, P < 0.001). After
intervention, fasting plasma LPS significantly increased (lean, median [IQR]
0.81 [0.63–1.45] EU/mL vs. 2.23 [1.33–3.83] EU/mL, P = 0.017; obese, median
[IQR] 0.76 [0.45–1.03] EU/mL vs. 1.44 [1.11–4.24], P = 0.014). However,
postprandial increases in leukocytes and plasma LPS were unaffected by van-
comycin in both groups. Moreover, we found no changes in plasma LBP, IL-6
and MCP-1 or in monocyte CCR2 expression. Despite major vancomycin-in-
duced disruption of the gut microbiota and increased fasting plasma LPS, the
postprandial inflammatory phenotype in lean and obese subjects was unaf-
fected in this study.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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Introduction
In the past decade, a plethora of animal and human
studies have shown an important link between the com-
position of the gut microbiota and metabolic diseases,
such as obesity and type 2 diabetes mellitus (T2D)
(Turnbaugh et al. 2009; Qin et al. 2012; Tremaroli and
Backhed 2012; Karlsson et al. 2013). These diseases are
characterized by a chronic state of low-grade systemic
inflammation (Chawla et al. 2011; Gregor and Hotamis-
ligil 2011). Translocation of metabolites derived from
intestinal bacteria into the systemic circulation has been
suggested to underlie the pathophysiology of this inflam-
matory state (Cani et al. 2007; Cani et al. 2008). For
example, mice fed a high-fat diet for 4 weeks had
increased amounts of bacterial DNA in both circulating
blood and mesenteric visceral adipose tissue (Amar et al.
2011). In humans, plasma concentrations of lipopolysac-
charide (LPS, also referred to as endotoxin), a cell wall
component of Gram-negative bacteria, have been associ-
ated with obesity (Basu et al. 2011), T2D (Pussinen
et al. 2011) and cardiovascular disease (Pussinen et al.
2007). Similarly, plasma LPS-binding protein (LBP), a
marker of LPS exposure, has been associated with obe-
sity and insulin resistance (Sun et al. 2010; Moreno-
Navarrete et al. 2012). Translocation of intestinal LPS
into the blood is actively mediated by enterocytes
through the apical scavenger receptor class B type 1 (SR-
BI), which binds LPS and mediates incorporation of LPS
in chylomicrons (Vishnyakova et al. 2003; Beaslas et al.
2009). Thus, endotoxemia may especially occur after a
meal enriched with fat.
Indeed, several human studies have shown after
administration of a high-fat meal, a postprandial
increase in plasma LPS (Erridge et al. 2007; Ghanim
et al. 2009; Laugerette et al. 2011), accompanied by a
systemic increase in IL-6 (Blackburn et al. 2006; Lund-
man et al. 2007; Khoury et al. 2010; Laugerette et al.
2011) and TNF-a (Nappo et al. 2002) and a shift
towards a proinflammatory phenotype of circulating
monocytes (Gower et al. 2011). This postprandial
inflammatory response was found to be increased in
obesity and T2D with the transient postprandial rise in
LPS being significantly higher in obese (Clemente-Post-
igo et al. 2012; Vors et al. 2015) and T2D (Harte et al.
2012) individuals compared to lean participants. More-
over, consumption of a high-fat meal increased plasma
IL-6 and TNF-a concentrations to a greater extent in
T2D compared to healthy subjects (Nappo et al. 2002).
Notably, in these trials endotoxin concentrations were
closely related to postprandial plasma chylomicrons
(CMs), further suggesting postprandial cotransport of
LPS with dietary lipids.
As abundance of Gram-negative bacteria is the main
driver of intestinal LPS concentration, we hypothesized
that the composition of gut microbiota is an important
factor in LPS translocation in the postprandial phase. In
order to test this hypothesis, we treated our subjects with
oral vancomycin, a broad-spectrum antibiotic that targets
Gram-positive bacteria, resulting in overgrowth of Gram-
negative strains and increasing luminal LPS concentra-
tions. In this study, we aimed to assess the effect of oral
vancomycin on postprandial LPS translocation and the
inflammatory response in lean subjects and in obese sub-
jects who fulfil the metabolic syndrome criteria.
Methods
Study design
Lean (body mass index [BMI] between 18.5 and 25 kg/
m2) and obese (BMI ≥ 30 kg/m2), metabolic syndrome
(≥3/6 criteria: waist circumference >102 cm; blood pres-
sure ≥130 mmHg systolic or ≥85 mmHg diastolic; fasting
plasma glucose ≥5.6 mmol/L; high-density lipoprotein
cholesterol [HDL-C] <1.03 mmol/L; fasting triglycerides
≥1.7 mmol/L; homeostatic model assessment-insulin resis-
tance [HOMA-IR] >2.2) male subjects aged 18–75 years
were recruited via local advertisements. Subjects were
excluded if they met one of the following criteria: use of
any medication; use of antibiotics or proton pump inhibi-
tors in the past 3 months; a medical history of type 1 or
2 diabetes, stroke, myocardial infarction, pacemaker, or
cholecystectomy; smoking; use of >5 units of alcohol
daily; recreational drug use; use of pre-, pro- or synbi-
otics. All participants received oral vancomycin 500 mg
four times a day for 7 days. High-fat meal tests were
scheduled before and after vancomycin intervention. To
ensure a complete wash-out of the study medication,
postintervention visits were scheduled two days after ces-
sation of vancomycin. Subjects were asked to refrain from
strenuous exercise during the study and to keep 3-day
online food diaries in the days preceding the study visits.
All participants gave written informed consent for partici-
pation in the study. The study was approved by the Insti-
tutional Review Board of the Amsterdam UMC, location
AMC in Amsterdam, the Netherlands, and conducted in
accordance with the Declaration of Helsinki (version
2013).
High-fat meal tests
Subjects visited the hospital after an overnight fast of at
least 10 h. After measurement of height, weight, waist
and hip circumference, and blood pressure, a cannula was
inserted into the antecubital vein for blood sampling.
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Blood samples were collected before (t = 0 h) and after
(t = 2 h and t = 4 h) ingestion of the liquid high-fat
meal (fresh cream, 35% fat, Albert Heijn, Zaandam, the
Netherlands, 93 E% fat, 4 E% carbohydrate, 3 E% pro-
tein) containing 335 kcal, 35 g fat of which 23 g saturated
and 12 g mono-unsaturated, 3.0 g carbohydrate of which
3.0 g sugars, and 2.5 g protein per 100 mL in a dosage of
50 g of fat per square meter body surface area (BSA)
(Klop et al. 2013). BSA was calculated using the following
formula: BSA (m2) = √((height in cm 9 weight in kg)/
3600) (Mosteller 1987). During the high-fat meal tests,
subjects were not allowed to eat or drink, except water,
and refrained from physical activity.
Biochemical analyses
Blood was collected in Vacutainer tubes containing hep-
arin, Ethylenediaminetetraacetic acid (EDTA), or spray-
coated silica and a polymer gel for serum separation
(Beckton Dickinson, Franklin Lakes, NJ), centrifuged at
1550 g (15 min, 4°C) and plasma and serum were stored
at 80°C until further analyses. Plasma glucose was
determined with a commercial assay on a Cobas 8000
c702 analyzer (Roche, Basel, Switzerland). Plasma insulin
was determined using the ADVIA Centaur XP
Immunoassay System (Siemens, Erlangen, Germany),
according to the manufacturer’s protocol. Plasma total
cholesterol, HDL-C, and triglycerides were determined
using commercial assays (Diasys and WAKO) on the
Selectra (Sopachem, Ochten, the Netherlands) according
to the manufacturer’s instructions. Low-density lipopro-
tein cholesterol (LDL-C) levels were calculated using the
Friedewald formula. Apolipoprotein (apo) B and apo A1
were analyzed using a commercial nephelometric assay on
a Selectra autoanalyzer.
Plasma for LPS measurements was transferred and
stored using endotoxin-free materials only. LPS concentra-
tions (i.e., endotoxin activity in EU/mL) were determined
using the Endosafe-MCS (Charles River Laboratories,
Lyon, France) based on the Limulus Amebocyte Lysate
(LAL) kinetic chromogenic methodology measuring color
intensity directly related to the endotoxin activity present
in a sample as previously described (Everard et al. 2013).
Briefly, plasma was first diluted 1/10 with endotoxin-free
buffer (Charles River Laboratories, Lyon, France) and
endotoxin-free LAL reagent water (Charles River Laborato-
ries, Lyon, France) to minimize interferences in the reac-
tion and then heated for 15 min at 70°C. Each sample was
further diluted with LAL water and treated in duplicate.
The dilution was chosen in order to fully recover the LPS
spikes (>70%). Two spikes for each sample were included
in the determination. All samples were validated for the
recovery and the coefficient variation. The lower limit of
detection was 0.005 EU/mL. Plasma concentrations of IL-
6, MCP-1, and LBP were determined using commercially
available ELISA kits (IL-6 Human ELISA Kit, High Sensi-
tivity, Thermo Fisher Scientific, Waltham, MA; Human
CCL2 (MCP-1) ELISA Ready-SET-Go!, eBioscience, San
Diego, CA; LBP, Human, ELISA kit, Hycult Biotech Inc.,
Plymouth Meeting, PA, respectively) according to the man-
ufacturer’s instruction. Blood cell counts were determined
automatically using an XN-9000 analyzer (Kobe, Hyogo
Prefecture, Japan) according to the manufacturer’s instruc-
tions within 45 min after collection in EDTA-coated tubes
that were kept at room temperature.
Gut microbiota analyses
Fecal samples were collected by the participants at home,
stored at 4°C, transported to the hospital within 24 h and
stored at 80°C until further processing. Before collec-
tion, subjects received three feces collection tubes (Faeces
tubes 76 9 20 mm, N€umbrecht, Germany) and sample
collection instruction. Total genomic DNA was isolated
from 250 mg of feces using an adapted repeated bead-
beating method (Salonen et al. 2010). 16S genes where
amplified with index primers with an adapted PCR
method (Kozich et al. 2013). After confirmation of PCR
products on agarose gel the samples were purified and
equal molar pooled before being analyzed by Illumina
Miseq (V3,600) sequencing (Kozich et al. 2013) (see Sup-
plements (https://figshare.com/s/25e137d98f1d736ab5e2)).
To allow interpretation of the sequences, forward and
reverse reads were length trimmed at 240 and 210 nucleo-
tides respectively and amplicon sequence variants (ASVs)
were inferred and merged using dada2 V1.5.2 (Callahan
et al. 2016). Taxonomy was assigned using dada2 imple-
mentation of the RDP classifier (Wang et al. 2007) and
SILVA (Quast et al. 2013) 16S ribosomal database V128.
Microbiota data were further analyzed and visualized using
phyloseq (McMurdie and Holmes 2013), vegan (Oksanen
et al. 2018) and picante (Kembel et al. 2014). Differences in
beta-diversity were tested with permutational multivariate
analysis of variance using weighted UniFrac (Lozupone
and Knight 2005). All statistical tests concerning alpha and
beta-diversity were performed on rarefied ASV tables.
To determine the abundance of intact bacteria before
and after vancomycin, fecal bacteria were stained with the
nucleic acid stain SytoBC (ThermoFisher Scientific, Invit-
rogen, Carlsbad, CA). Frozen fecal samples (100 mg) were
diluted 1:10 in phosphate buffered saline (PBS) with
cOmpleteTM Protease Inhibitory Cocktail (Roche, Basel,
Switzerland). All steps were performed on ice. Samples
were vigorously shaken for 10 min to obtain a homoge-
nized solution which was centrifuged at 400g for 5 min
to separate the bacteria from large debris. Next, 100 µL
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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of the supernatant was taken and centrifuged for 5 min at
8000g to pellet the bacteria. The pellet was washed with
1 mL of PBS. Lastly, bacteria were stained with 1:4000
diluted SytoBC stain in a 0.9% NaCl solution with
0.1 mol/L (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) (HEPES). Stained bacteria were measured on a BD
FACS Canto II (Becton, Dickinson, Franklin Lakes, NJ)
and analyzed using FlowJo software (version 10.0 FlowJo,
LLC, Ashland, OR). Threshold settings were set to the
minimal allowable voltage for side scatter to be able to
measure small particles. At least 50.000 events were
counted. The gating strategy is outlined in Figure S1
(https://figshare.com/s/515d569aff0c63e01a92).
Monocyte flow cytometry
Seven hundred microliters of whole blood was lysed in
6.3 mL red blood cell lysis buffer (Affymetrix, eBioscience,
San Diego, CA) for 15 min. The reaction was stopped by
the addition of 28 mL PBS. After centrifugation at 387g
(5 min, 4°C) the peripheral blood mononuclear cells
(PBMCs) were harvested. The PBMCs were suspended in
200 µL PBS and incubated with fluorochrome labeled anti-
bodies (PE-Cy7, mouse anti-human CD14, BD Pharmin-
gen, clone: M5E2, ref# 557742, lot# 6273595, 1/50 dilution;
APC-H7, mouse anti-human CD16, BD Pharmingen,
clone: 3G8, ref# 560195, lot# 5061807, 1/50 dilution;
PerCP-Cy5.5, mouse anti-human HLA-DR, BD Pharmin-
gen, clone: G46-6, ref# 560652, lot# 6098644, 1/50 dilution;
Alexa Fluor 647, mouse anti-human CD192 (CCR2), BD
Pharmingen, clone: 48607, ref# 558406, lot# 6165900, 1/50
dilution) for 15 min (room temperature, dark). After incu-
bation, the labeled cells were washed with 140 µL PBS and
centrifuged at 441g (3 min, 4°C). The cell pellet was resus-
pended in 200 µL PBS. Samples were analyzed on a BD
FACS Canto II (Becton, Dickinson, Franklin Lakes, NJ).
Five thousand monocyte events were counted per sample.
Monocyte subsets (i.e., classical, intermediate, and nonclas-
sical monocytes) were classified according to HLA-DR,
CD14, and CD16 expression (classical: CD14++, CD16–;
intermediate: CD14++, CD16+; nonclassical: CD14+,
CD16+). The gating strategy is outlined in Figure S2
(https://figshare.com/s/19152c97212b53a10ff7). Within the
monocyte subsets the expression of C-C chemokine recep-
tor type 2 (CCR2) was determined. The delta median fluo-
rescence intensity (DMFI = MFI surface staining – MFI
backbone [CD14, CD16, HLA-DR]) was analyzed using
FlowJo software (version 10.0 FlowJo, LLC, Ashland, OR).
Ex vivo monocyte stimulation
PBMCs were isolated using a LymphoprepTM (Axis-Shield,
Dundee, Scotland) density gradient and subsequent CD14+
monocyte isolation was conducted by magnetic activated cell
sorting (MACS) using human CD14-coated MicroBeads
according to the manufacturer’s instructions (MACS, Mil-
tenyi Biotec, Leiden, the Netherlands). Next, the monocytes
were counted (Casy TT, Roche Innovatis, Basel, Switzerland)
and plated into a 96-well flat-bottom plate (1E5 monocytes/
well), followed by culturing in Roswell Park Memorial Insti-
tute (RPMI) + GlutaMAX supplemented with 25 mmol/L
HEPES and 1% penicillin/streptomycin (Gibco, Dun Lao-
ghaire, County Dublin, Ireland). Subsequently, monocytes
were stimulated for 24 h with either RPMI, 10 ng/mL LPS
or 10 lg/mL Pam3Cys at 37°C, 5% CO2 after which the
supernatants were collected and stored at 20°C. Cytokine
production (IL-1b, TNF-a, MCP-1, IL-6 and IL-10) was
determined in supernatants using LEGENDplexTM bead-
based immunoassay according to the manufacturer’s
instructions (Biolegend, San Diego, CA).
Statistical analyses
Data were checked for normality with the Shapiro–Wilk
test and by visually assessing histograms and normality
plots. Effects of vancomycin on fasting parameters were
assessed using the paired t test for normal continuous vari-
ables and the Wilcoxon signed rank test for other variables.
One-way ANOVA for repeated measures (rm-ANOVA) for
normal continuous variables and the Friedman test for
other variables, with Bonferroni post hoc testing, was used
to assess effects of the high-fat meal on postprandial
parameters. Two-way repeated measures ANOVA with
Bonferroni post hoc testing with time after the meal (time)
and treatment (pre vs. post intervention) as factors was
used to determine the effect of treatment (time 9 treat-
ment interaction) on postprandial parameters. Statistical
analyses were performed using SPSS Statistics software,
version 24 (IBM, Armonk, New York). Data are provided
as mean with standard deviation (SD) or median with
interquartile range (IQR). P-values < 0.05 were considered
statistically significant. All authors had access to the study
data and reviewed and approved the final manuscript.
Results
We included 10 lean and 10 obese Caucasian males. Base-
line characteristics are summarized in Table 1. All obese
subjects met the metabolic syndrome criteria and were
insulin resistant (HOMA-IR score ≥ 2.2). All subjects
completed the study. No side effects of vancomycin treat-
ment were reported, apart from a mild increase in stool
frequency in eight subjects (four subjects in each group).
Caloric intake and body weight remained unchanged in
both groups throughout the study period (data not
shown).
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Vancomycin significantly alters fecal
microbiota composition
As expected, vancomycin significantly altered the relative
abundance of several bacterial groups (Fig. 1A). Specifically,
major Gram-positive taxa such as Clostridia and Bacteroidia
decreased, while Gram-negative taxa (Negativicutes and Pro-
teobacteria) and vancomycin-resistant Gram-positive taxa
such as Bacilli increased. Vancomycin decreased bacterial
diversity (Faith’s phylogenetic diversity pre and post interven-
tion respectively: lean, 56.9  7.8 vs. 21.4  6.6, P < 0.001;
obese, 53.9  7.8 vs. 21.0  5.9, P < 0.001; Fig. 1B). Non-
metric multidimensional scaling (NMDS) ordination of the
weighted UniFrac distances showed a significant shift of gut
microbiota composition after treatment (lean, P = 0.001;
obese, P = 0.001; Fig. 1C). The percentage of intact fecal bac-
teria as measured using SytoBC positivity was also signifi-
cantly reduced (lean, 82.4  5.8% vs. 38.4  11.4%,
P < 0.001; obese 76.1  15.7% vs. 35.4  9.0%, P < 0.001).
Vancomycin increases fasting LPS, without
significantly affecting the inflammatory
state
After vancomycin treatment, fasting LPS significantly
increased in both groups (lean, median [IQR]: 0.81
[0.63–1.45] versus 2.23 [1.33–3.83], P = 0.017; obese,
median [IQR]: 0.76 [0.45–1.03] versus 1.44 [1.11–4.24],
P = 0.014; Fig. 2). However, plasma LBP, IL-6 and MCP-1
did not change significantly (Table 2 and Table S1 [https://f
igshare.com/s/25e137d98f1d736ab5e2]). On a cellular level,
there was no effect on leukocyte counts (Table 2), leukocyte
subtypes (Table S2 [https://figshare.com/s/25e137d98f1d
736ab5e2]) and distribution of monocyte subtypes (i.e. clas-
sical, intermediate and nonclassical, Table S3). Monocyte
expression of CCR2, which was previously shown to be
positively correlated with lipid levels and inflammation
(Bernelot Moens et al. 2017; Verweij et al. 2018), did not
differ significantly in the fasting state upon vancomycin
treatment in the lean subjects but decreased in the obese
group (Table 2). Finally, vancomycin treatment resulted in
lower monocyte production of MCP-1 only in the lean
group upon ex vivo stimulation with LPS (Fig. S3 [https://f
igshare.com/s/2a0471bb2f08d5c9db56]). IL-1b production
was nonsignificantly reduced in Toll-like receptor 2
(TLR2)-stimulated monocytes after treatment compared to
baseline in both the lean and obese subjects. Production of
other cytokines (i.e. IL-6 and TNF-a) upon stimulation
with either Toll-like receptor 4 (TLR4) or TLR2 ligands did
not change after the intervention (Fig. S3 (https://figshare.c
om/s/2a0471bb2f08d5c9db56)).
Effect of a high-fat meal on postprandial
lipids
Plasma triglycerides significantly increased after a high-fat
meal in both groups. This increase was unaffected by the
intervention (Fig. S4 [https://figshare.com/s/1c7a7d643a6d
9588c8ad]). Plasma HDL-cholesterol decreased slightly
but significantly after the meal. LDL-cholesterol levels
decreased by about 10% after the meal in both groups
(Table S4 [https://figshare.com/s/25e137d98f1d736ab5e2]).
There was no effect of vancomycin on postprandial
plasma lipid concentrations (Table S4 [https://figshare.c
om/s/25e137d98f1d736ab5e2]).
Postprandial translocation of LPS is
unaffected by vancomycin treatment
LPS concentrations did not increase after a high-fat meal in
both groups (lean, median [IQR] at t = 0 h, t = 2 h and
t = 4 h, respectively: 0.81 [0.63–1.45], 1.19 [0.60–1.65] and
0.58 [0.46–0.63]; Friedman test P = 0.016; post hoc pair-
wise comparisons: t = 0 h versus t = 2 h, P = 1.000;
t = 0 h versus t = 4 h, P = 0.055, t = 2 h versus t = 4 h,
P = 0.029. Obese: median [IQR] at t = 0 h, t = 2 h and
t = 4 h, respectively: 0.76 [0.45–1.03], 0.54 [0.38–0.98] and
0.71 [0.51–1.52]; Friedman test P = 0.407). Although fast-
ing LPS concentrations increased after treatment in both
Table 1. Baseline characteristics.
Lean (n = 10) Obese (n = 10)
Age (years) 28.7 (8.7) 58.5 (7.3)
BMI (kg/m2) 22.8 (1.1) 34.6 (4.2)
BSA (m2) 1.99 (0.16) 2.41 (0.26)
Waist circumference (cm) 79.5 (6.0) 114.1 (14.5)
Waist/hip ratio 0.92 (0.04) 1.06 (0.06)
Systolic blood pressure
(mmHg)
130.8 (10.3) 155.9 (14.7)
Diastolic blood pressure
(mmHg)
78.0 (9.9) 93.8 (12.3)
Leukocytes (10E9/L) 5.3 (0.8) 6.0 (1.1)
Fasting glucose (mmol/L) 4.8 (0.2) 6.1 (0.7)
Fasting insulin (pmol/L)* 29 (15–43) 89 (66–128)
HOMA-IR* 0.9 (0.5–1.4) 3.4 (2.6–4.5)
Dietary intake
Energy (kcal/day) 2359 (652) 2046 (289)
Fat (g/day) 86.8 (30.9) 74.6 (18.0)
Carbohydrates (g/day) 279.3 (81.4) 218.0 (58.4)
Protein (g/day) 92.8 (31.2) 97.3 (12.8)
Fiber (g/day) 25.1 (9.7) 16.6 (25.1)
Data are represented as mean (SD) unless otherwise specified.
BMI, body mass index; BSA, body surface area; HOMA-IR, home-
ostasis model assessment of insulin resistance; n, number of
patients.
*Data are represented as median [IQR].
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groups, there was no effect of vancomycin treatment on
postprandial LPS concentrations (Fig. 3). LBP did not
increase after the high-fat meal, and vancomycin did not
affect postprandial LBP concentrations (Table S1 [https://f
igshare.com/s/25e137d98f1d736ab5e2]).
Postprandial monocyte activation is
unaffected by vancomycin treatment
Blood leukocyte counts significantly increased after the
high-fat meals in both groups, with no differences
between pre- and post-vancomycin treatment (Fig. 4 and
Table S2 [https://figshare.com/s/25e137d98f1d736ab5e2]).
This increase was mainly mediated by neutrophils
(Table S2 [https://figshare.com/s/25e137d98f1d736ab5e2]).
The increase in postprandial leukocyte counts was not
accompanied by an increase in plasma IL-6 or MCP-1
and vancomycin did not affect the concentrations of these
cytokines in the postprandial period (Table S1 [https://f
igshare.com/s/25e137d98f1d736ab5e2]). Distribution of
monocyte types and monocyte CCR2 expression (classical,
intermediate, nonclassical) also did not change after the
Figure 1. Effect of vancomycin on gut microbiota composition. Fecal microbial community characteristics of obese and lean subjects before
and after treatment. Vancomycin treatment resulted in significant changes in gut microbiota composition in both groups. (A) microbial
composition showing the 20 most abundant bacterial classes (upper part, preintervention; lower part, postintervention). (B) Faith’s phylogenetic
diversity distribution showed a significant decrease in alpha-diversity (lean, P < 0.001; obese, P < 0.001). (C) NMDS ordination of the weighted
UniFrac distances showed a significant shift in beta-diversity (lean, P = 0.001; obese, P = 0.001).
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intervention (Table S3 [https://figshare.com/s/25e137d98f
1d736ab5e2]).
Ex vivo stimulation experiments revealed that the pro-
duction of several cytokines by monocytes significantly
changed upon a high-fat meal challenge and vancomycin
treatment (Fig. 5) in the obese group but not in the
lean group. First of all, before intervention, there was a
decrease of MCP-1 production (upon stimulation with
medium only) in the obese group after a high-fat meal.
Furthermore, a high-fat meal resulted in a non-signifi-
cant downregulation of both IL-1b and TNF-a upon
TLR2 stimulation with Pam3Cys. Upon vancomycin
treatment, these effects were even more pronounced. IL-
6 production upon TLR2 stimulation was also downreg-
ulated in the obese group, but vancomycin treatment
blunted this effect. Other cytokines were not affected by
either the high-fat meal or vancomycin treatment
(Fig. 5).
Discussion
In this study, we investigated the effect of manipulation
of the gut microbiota by vancomycin on the inflamma-
tory response in the postprandial state. Despite large
shifts in fecal microbiota composition with a bloom in
Gram-negative bacteria and a concomitant significant
increase in fasting LPS, we did not observe a change in
several postprandial inflammatory markers after a high-
fat meal in lean and obese subjects with the metabolic
syndrome. This suggests that the LPS translocation may
not play a large role in the short-term postprandial
response in these groups.
Previously, several groups assessed the effects of meals
of varying composition on postprandial inflammation. To
our knowledge, we are the first to assess the effect of
manipulation of the gut microbiota on postprandial
inflammation. For example, it was shown that in lean and
obese subjects, a high-fat meal consisting of bread, palm
fat, salami, and boiled eggs of 1500 kcal resulted in a sig-
nificant increase in plasma IL-6 only in the obese group
(Schwander et al. 2014). Another study found an average
increase of plasma LPS of 50% after a high-fat meal con-
sisting of three slices of toast with 50 g butter in 12
healthy subjects, although there was no clear timepoint of
maximum LPS concentration (Erridge et al. 2007). Deop-
urkar et al. (2010) reported increased plasma LPS concen-
trations in healthy subjects 3 h after a meal consisting of
cream, but not after intake of an isocaloric glucose drink
or orange juice. Studies comparing T2D patients to
healthy controls found stronger increases in T2D in post-
prandial plasma IL-6 (Nappo et al. 2002) and LPS (Harte
et al. 2012) levels. Taken together, these studies indicate
that after a high-fat meal plasma LPS as well as inflam-
matory markers may increase, but they cannot confer a
Figure 2. Effect of vancomycin on fasting plasma LPS. Vancomycin
treatment significantly increased fasting plasma LPS in both groups
(Wilcoxon signed rank test; lean, P = 0.017; obese, P = 0.014).
Lines at median and IQR.
Table 2. Effect of vancomycin on fasting leukocyte counts, LBP, and inflammatory markers.
Preintervention Postintervention P
Leukocytes (10E9/L) Lean 5.3 (0.8) 5.4 (1.0) 0.752
Obese 6.0 (1.1) 6.1 (0.6) 0.718
LBP Lean 10.44 (1.46) 11.04 (2.30) 0.258
Obese 12.03 (2.55) 11.86 (2.61) 0.811
IL-6 (pg/mL) Lean 0.83 (1.82) 1.07 (1.56) 0.417
Obese 2.03 (2.57) 2.16 (3.04) 0.720
MCP-1 (pg/mL) Lean 44.2 (25.5) 50.3 (21.9) 0.538
Obese 111.5 (107.9) 91.6 (118.4) 0.361
CCR2 (MFI) Lean 628.0 (194.2) 611.2 (149.1) 0.649
Obese 617.2 (195.6) 518.2 (145.7) 0.029
Fasting blood leukocyte counts, plasma inflammatory markers and monocyte CCR2 expression before and after vancomycin treatment. CCR2,
chemokine receptor 2; IL-6, interleukin-6; LBP, lipopolysaccharide-binding protein; MCP-1, monocyte chemoattractant protein 1. n = 10 per
group. Data are represented as mean (SD).
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causal relationship between postprandial LPS transloca-
tion and low-grade inflammation observed after acute
consumption of dietary fat.
Our findings add to previous insights on the pathophysi-
ology of the inflammatory response in the postprandial per-
iod. We observed several changes induced by a high-fat meal
in both the lean and the obese group. For example, leukocyte
counts significantly increased after the meal in lean as well as
in obese subjects, as was previously described (Klop et al.
2013). Moreover, the meal influenced ex vivo production of
several cytokines by monocytes in the obese group. Specifi-
cally, MCP-1 production in unstimulated monocytes and
IL-1b, TNF-a and IL-6 production in TLR2-stimulated
monocytes were lower 4 h after a high fat meal. We were
unable to reproduce previous observations of a postprandial
increase in monocyte activation (Alipour et al. 2008; Gower
et al. 2011; Esser et al. 2013), although in those studies
monocyte CCR2 expression was not assessed. Moreover, we
did not observe an increase in plasma LPS, IL-6 or MCP-1
after the high-fat meal, which is in accordance with some
(Gower et al. 2011; Meher et al. 2014; Fogarty et al. 2015;
Milan et al. 2017) but not other (Ghanim et al. 2009; Lauger-
ette et al. 2011; Dijk et al. 2012) studies.
Oral vancomycin treatment significantly changed the
composition of the gut microbiota as shown previously
(Vrieze et al. 2014; Reijnders et al. 2016), with a relative
overgrowth of potentially pathogenic Gram-negative taxa
such as Proteobacteria. Concomitantly, we found increases
in fasting plasma LPS levels, possibly due to the increased
presence of Gram-negative bacteria inducing an excess of
LPS in the intestinal lumen. Interestingly, ex vivo MCP-1
production by monocytes that were incubated with LPS
slightly decreased after vancomycin treatment only in lean
fasting subjects. Similarly, a 7-day treatment of 12 healthy
subjects with ciprofloxacin, vancomycin and metronidazole
was shown to lower fasting LPS-induced TNF-a production
in isolated monocytes (Lankelma et al. 2016). Nevertheless,
in the postprandial phase, production of cytokines by stimu-
lated monocytes was unaffected by the intervention in our
study. Moreover, both fasting and postprandial leukocyte
counts, monocyte activation markers and plasma IL-6 and
MCP-1 were unaffected by vancomycin treatment. Finally,
postprandial LPS concentrations as well as LBP levels were
unaffected by treatment, suggesting that manipulation of the
gut microbiota did not increase postprandial bacterial
translocation.
Figure 3. Postprandial LPS concentrations. LPS concentrations did
not increase after the high-fat meal in both the lean (A) and obese
(B) group. Vancomycin treatment did not affect postprandial LPS
concentrations (two-way repeated measures ANOVA, time 9
treatment interaction: lean, P = 0.318, obese, P = 0.714). Lines
show median and IQR.
Figure 4. Postprandial blood leukocyte counts. Leukocyte counts
significantly increased after the meal in both the lean (A) and obese
(B) group (one-way rm-ANOVA: lean, P = 0.006 preintervention
and P = 0.001 postintervention; obese, P = 0.001 preintervention
and P = 0.003 postintervention). Vancomycin treatment did not
affect postprandial leukocyte counts. Graphs show mean and SD.
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Apart from LPS measurement, quantification or
sequencing of 16S rDNA in plasma is sometimes used as
marker of translocation. Although this would be interest-
ing to assess, this is not the only way to do so, nor the
gold standard. Moreover, in tissues with low microbial
biomass, there may be the issue of contamination (Kim
et al. 2017).
LPS toxicity is related to several factors, such as bacte-
rial origin (Schromm et al. 1998) and binding to plasma
proteins (e.g. LBP, lipoproteins, CD14, endotoxin core
antibodies) (Thompson et al. 2008). As LBP may be
upregulated after LPS exposure in a setting of septic
shock (Opal et al. 1999), it is sometimes used as a marker
of LPS exposure. While LBP can augment LPS-induced
activation of monocytes by accelerating binding to CD14
at low concentration, it has inhibitory effects in high con-
centrations (Gutsmann et al. 2001; Zweigner et al. 2001;
Thompson and Kitchens 2006). In our study we observed
increased fasting plasma LPS after vancomycin interven-
tion. However, this was not accompanied by increase in
LBP. Concomitantly, no change in inflammatory markers
was found.
It should be noted that we investigated the effect of a
short-term intervention (7 days) on the postprandial
response to a single high-fat meal. Although this duration
is sufficient to significantly alter gut microbiota composi-
tion (Reijnders et al. 2016), it cannot be ruled out that
long-term microbiota manipulation may alter postpran-
dial inflammatory mechanisms. The exact role of the gut
microbiota in inflammation in high-fat diets as opposed
to a single high-fat meal in humans is unclear. Previously,
it was shown that in mice, a chronic high-fat diet
increased endotoxemia 2–3 fold (Cani et al. 2007). Simi-
larly, 18 healthy subjects that were overfed (+760 kcal/
day) for 8 weeks showed increased postprandial endotox-
emia upon a high-fat meal (Laugerette et al. 2014). Thus,
even though we did not see an effect of the intervention
on postprandial inflammation in this study, we cannot
rule out a role for long-term changes in intestinal micro-
biota composition or intestinal permeability in postpran-
dial inflammation.
Our study has several strengths and weaknesses. As
vancomycin treatment induced large shifts in gut micro-
biota composition, we were able to directly assess a
potential causal role of intestinal microbes in postprandial
inflammation. Moreover, our meal was high in fat con-
tent, which was reflected by a significant increase of post-
prandial triglycerides in both groups. Thus, our study was
well suited to test the hypothesis of postprandial chylomi-
cron-associated LPS translocation. However, it should be
noted that we were only able to assess the effect of the
intervention on the fecal microbiota. As lipid uptake pre-
dominantly takes place in the small intestine, we cannot
rule out that the intervention was not sufficient to
increase luminal LPS concentrations and potentially alter
LPS translocation in the small intestine. Of note, the
increase in fasting plasma LPS could both reflect
increased luminal LPS concentrations due to overgrowth
of Gram-negative bacteria or increased intestinal perme-
ability. In this study, we did not assess intestinal perme-
ability.
Secondly, we evaluated the postprandial inflammatory
response in a lean healthy group and in an obese, metabolic
syndrome group, as these groups were previously shown to
have a different postprandial inflammatory response. How-
ever, as the groups had significantly different characteris-
tics, such as age, dietary intake and baseline inflammatory
parameters, we could not directly compare these two
groups in this study. Instead, we assessed the effect of a
vancomycin intervention in both groups separately, allow-
ing us to do paired observations within the groups. There-
fore, the study had significant power to detect differences
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Figure 5. Effect of a high-fat meal on monocyte cytokine production. Monocytes of lean and obese subjects were isolated before (t = 0 h)
and after (t = 4 h) a high-fat meal. Monocytes were stimulated with RPMI (negative control), LPS (TLR4 stimulation) or Pam3Cys (TLR2
stimulation). After 24 h, concentrations of MCP-1, IL-1b, TNF-a and IL-6 were measured in the supernatant. The heatmap shows the effects of
the meal on monocyte cytokine production before (pre) and after (post) vancomycin treatment. Red indicates upregulated cytokine production
after the meal compared to before the meal. Blue indicates a downregulation of cytokine production after the meal compared to before the
meal. n = 10 per group. ^P < 0.1, *P < 0.05, **P < 0.01. RPMI, Roswell Park Memorial Institute.
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between pre- and post-intervention, despite the groups
being relatively small. Nevertheless, adding a placebo-arm
would have increased the power. Thus, it would be inter-
esting to perform a similar placebo-controlled study in
age-matched lean and obese subjects.
In conclusion, manipulation of the gut microbiota by a
short-term course of broad-spectrum antibiotics led to a
large shift in gut microbiota composition and a signifi-
cant increase in plasma LPS, but did not affect the physi-
ology of postprandial inflammation in lean or obese
subjects in this study. This suggests that LPS translocation
may not drive the postprandial inflammatory response
upon a single high-fat meal.
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Supporting Information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.:
Figure S1. Flow cytometry gating strategy for bacteria in
fecal sample. Forward and side scatter (A), SytoBC his-
togram with negative control (no stain) (B), example of
stained bacteria from a pre-vancomycin fecal sample (C)
and example from a post-vancomycin fecal sample (D).
Figure S2. Flow cytometry gating strategy for monocytes
and their subtypes in a PBMC sample. Leukocytes were
gated using forward and side scatter (A), monocytes were
selected using CD14, CD16 and HLA-DR (B and C) and
finally the monocyte subtypes were gated. We distin-
guished classical (CD14++ CD16-), intermediate
(CD14++, CD16+) and non- classical (CD14+ CD16+)
monocytes (D).
Figure S3. Monocytes of fasting lean and obese subjects
were isolated and stimulated with RPMI (negative
control), LPS (TLR4 stimulation) or Pam3Cys (TLR2
stimulation). After 24h, concentrations of MCP-1, IL-1b,
TNF-a and IL-6 were measured in the supernatant. The
heatmap shows the effects of vancomycin on monocyte
cytokine production. Red indicates upregulated cytokine
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production after treatment compared to before treatment.
Blue indicates a downregulation of cytokine production
after treatment compared to before treatment. n = 10 per
group. ^p < 0.1, *p < 0.05.
Figure S4. Triglycerides significantly increased after the
meal in both the lean (A) and obese (B) group (oneway
repeated measurements-ANOVA: lean, p < 0.001 both
pre- and post-intervention; obese, p < 0.001 both
pre- and post-intervention). There was no effect of van-
comycin on postprandial triglyceride concentrations
(two-way repeated measurements-ANOVA, time * treat-
ment interaction: lean, p = 0.436, obese, p = 0.483).
Graphs show mean and SD.?
Table S1. Plasma LBP and cytokines fasting at fasting, 2
and 4 hours after an oral fatload before (pre) and after
(post) vancomycin treatment. IL-6, Interleukin-6. LBP,
lipopolysaccharde-binding protein; MCP-1, monocyte
chemoattractant protein 1; p meal represents differences
between t = 0h, t = 2h, and t = 4h (one-way repeated
measurements-ANOVA). p intervention represents the
overall intervention effect (two-way rm-ANOVA, time *
treatment interaction). Data are mean (SD).
Table S2. Blood differentiated leukocyte counts at fasting,
2 and 4 hours after an oral fatload before (pre) and after
(post) vancomycin treatment. p meal represents differ-
ences between t = 0h, t = 2h, and t = 4h (oneway
rm-ANOVA). p intervention represents the overall inter-
vention effect (two-way rm-ANOVA, time *treatment
interaction). Data are mean (SD).
Table S3. Monocyte type distribution based on flow
cytometry at fasting and 4 hours after an oral fatload before
(pre) and after (post) vancomycin treatment. Monocytes
were categorized as type 1 (classical), type 2 (intermediate)
or type 3 (non-classical) based on CD14/CD16 expression
(type 1, CD14++ CD16; type 2, CD14++CD16+; type 3,
CD14+CD16+). CCR2, C-C chemokine receptor type 2. p
meal represents differences between t = 0h and t = 4h
(paired t-test). p intervention represents difference in delta
(t = 4h minus t = 0h) between pre and post intervention
(paired t-test). Data are mean (SD).
Table S4. Plasma concentrations of lipids fasting and 2
and 4 hours after an oral fat lipoprotein cholesterol; LDL-
c, low-density lipoprotein cholesterol; n, number of
patients. p meal represents differences between t = 0h,
t = 2h, and t = 4h (one- way repeated measurement-
ANOVA). p intervention represents the overall interven-
tion effect (two-way repeated measurement-ANOVA, time
* treatment interaction). Data are mean (SD).
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